CAR-iNKT cells therapy (North Jiangsu People's Hospital)

CAR-iNKT细胞疗法(苏北人民医院)

Report date: 2024/11/25 20:00:28

Base Information

Drug NameCAR-iNKT cells therapy (North Jiangsu People's Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionImmunologic cytotoxicityAnti-CD19

TargetsB-lymphocyte antigen CD19

Therapy Area/IndicationsLymphoma, B-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesAffiliated Hospital Of Jiangsu University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAffiliated Hospital Of Jiangsu University

Active IndicationsN/A

Inactive IndicationsLymphoma, B-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A